Browse > Article

Ginsenosides Prevent High Glucose-induced Apoptosis in HT22 Cells  

Lee, Jeong-Chi (Department of Clinical Pathology, Gwangju Health College University)
Jang, Seon-Il (School of Alternative Medicine & Health Science, College of Alternative Medicine, Jeonju University)
Publication Information
Journal of Physiology & Pathology in Korean Medicine / v.23, no.5, 2009 , pp. 1019-1024 More about this Journal
Abstract
Diabetic neuropathy is characterized by the decrease of cell viability in neuron, which is induced by the hyperglycemia. HT22 cell is the neuron cell line originated from hippocampus. Ginsenosides have been reported to retain anti-diabetic effect. However, the preventive effect of ginsenosides in the condition of diabetic neuropathy was not elucidated. Thus, this study was conducted to examine the protective effect of ginsenoside total saponin (GTS), panoxadiol (PD), and panoxatriol (PT) in the high glucose-induced cell death of HT22 cells, an in vitro cellular model for diabetic neuropathy. In present study, high glucose increased lactate dehydrogenase(LDH) activity, the lipid peroxide(LPO) formation and induced the decrease of cell viability. These effects were completely prevented by the treatment of GTS, but partially prevented by the treatment of PD and PT. High glucose also increased the expression of Bax and cleaved form of caspase-3 but decreased that of Bcl-2. These effects of high glucose on Bax, Bcl-2 and cleaved form of caspase-3 were completely prevented by the treatment of GTS, but partially prevented by the treatment of PD and PT in HT22 cells. In conclusion, ginsenosides prevented high glucose-induced cell death of hippocampal neuron through the inhibition of oxidative stress and apoptosis in HT 22 cells.
Keywords
diabetic neuropathy; hippocampus; ginsenosides; high glucose; oxidative stress; apoptosis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Kles, K.A., Vinik, A.I. Pathophysiology and treatment of diabetic peripheral neuropathy: the case for diabetic neurovascular function as an essential component. Curr Diabetes Rev. 2: 131-145, 2006   DOI   ScienceOn
2 Misawa, S., Kuwabara, S., Ogawara, K., Kitano, Y., Yagui, K., Hattori, T. Hyperglycemia alters refractory periods in human diabetic neuropathy. Clin Neurophysiol. 115: 2525-2529, 2004   DOI   ScienceOn
3 Yip, T.T., Lau, C.N., Kong, Y.C., Yung, K.H., Kim, J.H., Woo, W.S. Ginsenoside compositions of Panax ginseng C.A. Meyer tissue culture and juice. Am J Chin Med. 13: 89-92, 1985   DOI   ScienceOn
4 Ohkawa, H., Ohishi, N., Yagi, K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 95: 351-358, 1979   DOI   ScienceOn
5 Kuhad, A., Chopra, K. Curcumin attenuates diabetic encephalopathy in rats: behavioral and biochemical evidences. Eur J Pharmacol. 576(1-3):34-42, 2007   DOI   ScienceOn
6 Kuhad, A., Sethi, R., Chopra, K. Lycopene attenuates diabetes-associated cognitive decline in rats. Life Sci. 83(3-4):128-134, 2008   DOI   ScienceOn
7 Gold, A.E., Deary, L.J., Jones, R.W., O'Hare, J.P., Reckless, J.P., Frier, B.M. Severe deteriorations in cognitive function and personality in patients with long-standing diabetes: A complication of diabetes or a consequence of treatment? Diabetes Med. 11: 499-505, 1994   DOI   ScienceOn
8 Kiefer, D., Pantuso, T. Panax ginseng. Am Fam Physician 68: 1539-1542, 2003   PUBMED
9 Xie, J.T., Mehendale, S.R., Wang, A., Han, A.H., Wu, J.A., Osinski, J., Yuan, C.S. American ginseng leaf: ginsenoside analysis and hypoglycemic activity. Pharmacol Res. 49: 113-117, 2004   DOI   ScienceOn
10 Kumar, A., Kaundal, R.K., Iyer, S., Sharma, S.S. Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy. Life Sci. 80: 1236-1244, 2007   DOI   ScienceOn
11 Alvarez, E.O., Beauquis, J., Revsin, Y., Banzan, A.M., Roig, P., De Nicola, A.F., Saravia, F. Cognitive dysfunction and hippocampal changes in experimental type 1 diabetes. Behav Brain Res. 198(1):224-230, 2009   DOI   ScienceOn
12 Boulton, A.J. Diabetic neuropathy: classification, measurement and treatment. Curr Opin Endocrinol Diabetes Obes. 14: 141-145, 2007   DOI   PUBMED
13 Jang, M.H., Chang, H.K., Shin, M.C., Lee, T.H., Kim, Y.P., Kim, E.H., Kim, C.J. Effect of ginseng radix on c-Fos expression in the hippocampus of streptozotocin-induced diabetic rats. J Pharmacol Sci. 91: 149-152, 2003   DOI   ScienceOn
14 Saravia, F.E., Beauquis, J., Revsin, Y., Homo-Delarche, F., de Kloet, E.R., De Nicola, A.F. Hippocampal neuropathology of diabetes mellitus is relieved by estrogen treatment. Cell Mol Neurobiol. 26(4-6):943-957, 2006   DOI
15 Beauquis, J., Roig, P., Homo-Delarche, F., De Nicola, A., Saravia, F. Reduced hippocampal neurogenesis and number of hilar neurones in streptozotocin-induced diabetic mice: reversion by antidepressant treatment. Eur J Neurosci. 23(6):1539-1546, 2006   DOI   ScienceOn
16 Bibbo, C., Patel, D.V. Diabetic neuropathy. Foot Ankle Clin. 11: 753-774, 2006   DOI   ScienceOn
17 Camera, A., Hopps, E., Caimi, G. Diabetic microangiopathy: physiopathological, clinical and therapeutic aspects. Minerva Endocrinol. 32: 209-229, 2007   PUBMED
18 Post, A., Muller, M.B., Engelmann, M., Keck, M.E. Repetitive transcranial magnetic stimulation in rats: evidence for a neuroprotective effect in vitro and in vivo. Eur J Neurosci. 11(9):3247-3254, 1999   DOI   ScienceOn
19 Sharifi, A.M., Mousavi, S.H., Farhadi, M., Larijani, B. Study of high glucose-induced apoptosis in PC12 cells: role of bax protein. J Pharmacol Sci. 104: 258-262, 2007   DOI   ScienceOn
20 Li, Z.G., Zhang, W., Grunberger, G., Sima, A.A. Hippocampal neuronal apoptosis in type I diabetes. Brain Res. 946(2):221-231, 2002   DOI   ScienceOn
21 Schmidt, P., Holsboer, F., Spengler, D. Beta(2)-adrenergic receptors potentiate glucocorticoid receptor transactivation via G protein beta gamma-subunits and the phosphoinositide 3-kinase pathway. Mol Endocrinol. 15(4):553-564, 2001   DOI   ScienceOn
22 Wong, W.W., Puthalakath, H. Bcl-2 family proteins: the sentinels of the mitochondrial apoptosis pathway. IUBMB Life. 60(6):390-397, 2008   DOI   ScienceOn
23 Cho, W.C., Chung, W.S., Lee, S.K., Leung, A.W., Cheng, C.H., Yue, K.K. Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats. Eur J Pharmacol. 21: 173-179, 2006   DOI   ScienceOn
24 Pop-Busui, R., Sima, A., Stevens, M. Diabetic neuropathy and oxidative stress. Diabetes Metab Res Rev. 22: 257-273, 2006   DOI   ScienceOn
25 Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72: 248-254, 1976   DOI   PUBMED   ScienceOn
26 Beauquis, J., Saravia, F., Coulaud, J., Roig, P., Dardenne, M., Homo-Delarche, F., De Nicola, A. Prominently decreased hippocampal neurogenesis in a spontaneous model of type 1 diabetes, the nonobese diabetic mouse. Exp Neurol. 210(2):359-367, 2008   DOI   ScienceOn
27 Jackson-Guilford, J., Leander, J.D., Nisenbaum, L.K. The effect of streptozotocin-induced diabetes on cell proliferation in the rat dentate gyrus. Neurosci Lett. 293: 91-94, 2000   DOI   ScienceOn
28 Waki, I., Kyo, H., Yasuda, M., Kimura, M. Effects of a hypoglycemic component of ginseng radix on insulin biosynthesis in normal and diabetic animals. J Pharmacobiodyn. 5: 547-554, 1982   DOI   PUBMED